Portfolio Performance Update – October 5, 2025

 Welcome back to my portfolio performance series!

Since my last update, there have been some significant movements across my holdings — both in terms of price action and position adjustments. Notably, I’ve averaged down on ALIVUS, lowering my overall acquisition cost.

Let’s walk through the changes.

---

🔄 Key Update

• ALIVUS was averaged at ₹932, bringing the new average acquisition price to ₹1,038.50.

---

📊 Current Portfolio Performance (As of October 5, 2025)

Stock	Entry Date	Exit Date	Avg Price	Current Price	P/L %
DODLA	5-Sep-2025	—	₹1,460.50	₹1,339.00	-8.32%
CHAMBLFERT	22-Aug-2025	—	₹561.00	₹519.60	-7.38%
THANGAMAYL	2-Aug-2025	—	₹1,904.10	₹2,081.70	9.33%
MARKSANS	6-Jul-2025	—	₹263.00	₹166.90	-36.54%
SCHNEIDER	20-Jun-2025	—	₹759.00	₹854.00	12.52%
VEDL	6-Jun-2025	—	₹446.40	₹471.50	5.62%
TARIL	30-May-2025	—	₹522.40	₹497.65	-4.74%
CMSINFO	24-May-2025	—	₹482.00	₹381.90	-20.77%
USHAMART	24-May-2025	—	₹325.00	₹463.05	42.48%
ALIVUS	16-May-2025	—	₹1,038.50	₹932.00	-10.26%
MOTILALOFS	18-Apr-2025	—	₹652.30	₹911.00	39.66%
BASF	11-Apr-2025	—	₹4,503.00	₹4,696.00	4.29%
SYMPHONY	11-Apr-2025	—	₹1,135.00	₹921.50	-18.81%
NSE:TCI	11-Apr-2025	—	₹1,089.00	₹1,215.20	11.59%
BBTC	4-Apr-2025	—	₹1,770.00	₹1,842.50	4.10%
TIMETECHNO	30-Mar-2025	—	₹210.65	₹220.10	4.49%
GRAVITA	30-Mar-2025	—	₹1,823.00	₹1,575.40	-13.58%

---

🏆 Top Performers

• ✅ USHAMART leads with a +42.48% gain.

• ✅ MOTILALOFS and SCHNEIDER continue strong momentum.

• ✅ NSE:TCI & VEDL also showing steady resilience.

⚠️ Laggards to Watch

• ❌ MARKSANS remains the biggest drag at -36.54%.

• ❌ CMSINFO and SYMPHONY have slid deeper into red.

• ❌ ALIVUS, even after averaging down, needs recovery tailwinds.

---

📌 Strategy Going Forward

• Holding strong on high-conviction laggards where fundamentals remain intact.

• Monitoring USHAMART & MOTILALOFS for potential partial profit booking.

• Open to adding dips on quality compounders like SCHNEIDER / TCI.